Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-01 9:10 pm Purchase | 2026-05-28 | 13D | Q32 BIO INC QTTB | ORBIMED ADVISORS LLC | 4,127,987 17.400% | 1,875,000 (+83.22%) | Filing History |
| 2026-05-15 4:38 pm Purchase | 2026-03-31 | 13G | XILIO THERAPEUTICS INC XLO | ORBIMED ADVISORS LLC | 642,000 9.990% | 642,000 (New Position) | Filing History |
| 2026-05-15 4:37 pm Sale | 2026-03-31 | 13G | RAPT THERAPEUTICS INC RAPT | ORBIMED ADVISORS LLC | 0 0.000% | -1,086,618 (Position Closed) | Filing History |
| 2026-05-15 4:35 pm Sale | 2026-03-31 | 13G | NEUROPACE INC NPCE | ORBIMED ADVISORS LLC | 2,096,527 6.200% | -517,657 (-19.80%) | Filing History |
| 2026-05-15 4:34 pm Purchase | 2026-03-31 | 13G | FORTE BIOSCIENCES INC FBRX | ORBIMED ADVISORS LLC | 884,230 4.300% | 374,230 (+73.38%) | Filing History |
| 2026-05-15 4:31 pm Sale | 2026-03-31 | 13G | AVALO THERAPEUTICS INC PAR AVTX | ORBIMED ADVISORS LLC | 475,165 2.100% | -712,135 (-59.98%) | Filing History |
| 2026-05-06 5:48 pm Unchanged | 2026-05-05 | 13D | Q32 BIO INC QTTB | ORBIMED ADVISORS LLC | 2,252,987 13.300% | 0 (Unchanged) | Filing History |
| 2026-05-05 6:55 pm Purchase | 2026-04-16 | 13D | TRAWS PHARMA, INC PAR TRAW | ORBIMED ADVISORS LLC | 1,876,198 11.900% | 1,115,374 (+146.60%) | Filing History |
| 2026-04-29 7:07 pm Purchase | 2026-04-14 | 13D | IKENA ONCOLOGY INC IKNA | ORBIMED ADVISORS LLC | 1,495,045 13.100% | 721,291 (+93.22%) | Filing History |
| 2026-04-23 8:42 pm Sale | 2026-04-21 | 13D | PRELUDE THERAPEUTICS INC PRLD | ORBIMED ADVISORS LLC | 12,935,071 16.000% | -2,781,571 (-17.70%) | Filing History |
| 2026-04-20 6:46 pm Sale | 2026-04-15 | 13D | SIONNA THERAPEUTICS INC SION | ORBIMED ADVISORS LLC | 2,967,722 6.600% | -737,237 (-19.90%) | Filing History |
| 2026-04-10 8:27 pm Sale | 2026-04-08 | 13D | ADICET BIO INC ACET | ORBIMED ADVISORS LLC | 844,787 8.800% | -78,500 (-8.50%) | Filing History |
| 2026-03-12 5:06 pm Unchanged | 2026-02-18 | 13D | Q32 BIO INC QTTB | ORBIMED ADVISORS LLC | 2,252,987 15.400% | 0 (Unchanged) | Filing History |
| 2026-03-04 9:12 pm Sale | 2026-03-02 | 13D | PMV PHARMACEUTICALS INC PMVP | ORBIMED ADVISORS LLC | 0 0.000% | -4,975,291 (Position Closed) | Filing History |
| 2026-02-17 6:33 pm Unchanged | 2025-12-31 | 13G | VISTAGEN THERAPEUTICS INC VTGN | ORBIMED ADVISORS LLC | 1,639,700 4.200% | 0 (Unchanged) | Filing History |
| 2026-02-17 6:27 pm Purchase | 2025-12-31 | 13G | INSPIREMD INC NSPR | ORBIMED ADVISORS LLC | 3,133,405 7.400% | 1,000,000 (+46.87%) | Filing History |
| 2026-02-17 6:23 pm Sale | 2025-12-31 | 13G | CYTOMX THERAPEUTICS INC CTMX | ORBIMED ADVISORS LLC | 3,525,650 2.100% | -4,935,850 (-58.33%) | Filing History |
| 2026-02-17 6:20 pm Purchase | 2025-12-31 | 13G | CYBIN INC CYBN | ORBIMED ADVISORS LLC | 2,422,600 4.900% | 2,422,600 (New Position) | Filing History |
| 2026-02-17 6:18 pm Sale | 2025-12-31 | 13G | C4 THERAPEUTICS INC CCCC | ORBIMED ADVISORS LLC | 883,534 1.000% | -2,684,812 (-75.24%) | Filing History |
| 2026-02-17 6:13 pm Purchase | 2025-12-31 | 13G | AVALO THERAPEUTICS INC PAR AVTX | ORBIMED ADVISORS LLC | 1,187,300 6.400% | 220,300 (+22.78%) | Filing History |